Knowledge Graph

Taking a daily multivitamin for two years makes older adults' brains function as if they are two years younger, based on better memory and thinking skills.

Taking a daily multivitamin for two to three years makes older adults' memory and thinking skills as good as those of people 2 to 4.8 years younger.

Older adults with mobility problems who have high levels of GDF15, osteopontin, VEGFA, TNFR1, and MMP7 in their blood lose physical function faster and are more likely to become severely disabled within two years, no matter what treatment they receive.

Liraglutide lowers blood sugar and improves how the body uses insulin in overweight, prediabetic people by directly activating GLP-1 receptors — and this works differently than losing weight or taking other drugs that raise GLP-1 levels.

Liraglutide improves blood sugar and insulin response in obese people with prediabetes by directly activating GLP-1 receptors — not by making them lose weight or by boosting natural gut hormones.

In vitamin D-deficient overweight or obese kids aged 10 to 18, taking 1000–2000 IU of vitamin D3 daily for six months lowers blood sugar and blood pressure and helps the body use insulin better, even though it doesn't change artery health or inflammation markers.

Older adults who move more naturally have lower levels of aging biomarkers and less mobility loss, but structured exercise programs don't lower those biomarkers even though they still prevent mobility loss.

Liraglutide improves insulin response and lowers blood sugar in people with obesity and prediabetes within two weeks, even without losing weight, because it directly activates GLP-1 receptors — something natural hormone boosters like sitagliptin cannot do.

Liraglutide lowers blood sugar and improves how the body uses insulin in overweight, prediabetic people within two weeks—without needing weight loss—and this effect is different from what diet or other diabetes drugs do.

Liraglutide improves blood sugar and insulin response in obese prediabetic adults by directly activating GLP-1 receptors, but sitagliptin — which raises the same hormones — does not.

Liraglutide lowers blood sugar in obese, prediabetic people by directly activating GLP-1 receptors, and this effect doesn't happen with dieting, sitagliptin, or natural hormone increases.

Liraglutide improves how the body uses insulin and lowers blood sugar in obese, prediabetic people within two weeks—before any weight loss—and blocking the GLP-1 receptor removes these benefits.